My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

A new study sheds light on how behavioral symptoms are related to daily functioning in people with Alzheimer’s disease.

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

A free database of biomarker information on neurodegenerative diseases was released with backing from Bill Gates, Johnson & ...

Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

However, some research suggests that poor sleep could raise your risk of Alzheimer’s. A study published in November found ...

The Alzheimer's Association of Greater Kentucky and Southern Indiana held the kickoff party on Wednesday for its Walk to End ...

Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics ...

A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age.